Follow us on:

Linkedin Facebook

Health

Companies engaged in biotechnology, pharmaceuticals, research services, home healthcare, hospital operations, long‑term care, and the manufacture and supply of medical equipment and supplies. The sector also includes pharmaceutical retailers and providers of health‑information services. UK‑listed companies in this sector include AstraZeneca plc, GlaxoSmithKline plc, Smith & Nephew plc, Hikma Pharmaceuticals plc, ConvaTec Group plc, Spire Healthcare plc and EMIS Group plc.

Aptamer Group

Aptamer Group AGM statement highlights contract wins and growing order book

Aptamer Group is holding its AGM today in York, where the Chairman will outline continued commercial progress, recent contract wins with major pharmaceutical companies, and an FY26 order book of £1.95 million...
intravenous (IV) line

AstraZeneca wins US approval for Imfinzi in early gastric and GEJ cancers

AstraZeneca has received US approval for Imfinzi combined with FLOT chemotherapy for adults with resectable early-stage and locally advanced gastric and gastroesophageal junction cancers...
AstraZeneca

AstraZeneca Plc to invest $2 billion in major Maryland manufacturing expansion

AstraZeneca has confirmed a $2 billion investment to expand its manufacturing presence in Maryland, including a larger biologics facility in Frederick and a new clinical manufacturing site in Gaithersburg...
GSK

GSK subsidiary TESARO starts legal action over Jemperli licence dispute

TESARO, part of GSK, has filed a case in the Delaware Chancery Court claiming AnaptysBio has breached its licence agreement for the cancer treatment Jemperli...
Halma plc

Halma Plc posts interim results and raises dividend by 7%

Halma plc has released its interim results for the six months to 30 September 2025, with full details available on its website and through the FCA’s National Storage Mechanism...
CVS Group plc

CVS Group reports steady sales growth and progress on strategy

CVS reported a 5.7 percent rise in sales and improved adjusted EBITDA for the four months to 31 October 2025, supported by stronger like for like growth and continued membership gains in its Healthy Pet Club scheme...
Ethtry plc

Ethtry appoints Patrick Chopard as new CEO

Ethtry PLC has named Patrick Chopard as its new Chief Executive Officer, bringing more than 15 years of financial markets experience from roles at Barclays, Deutsche Bank and Nomura...
Aptamer Group

Aptamer Group secures £192k contracts with global pharma, boosting FY26 order book to £1.95m

Aptamer Group announced two new contracts worth £192,000, including a fourth engagement with a top five global pharmaceutical company and a new deal targeting acute myeloid leukaemia...
Nuformix

Nuformix receives FDA clarification request and reports 408% oversubscription in Open Offer

Nuformix has received an FDA request for clarification on its Orphan Drug Designation application for tranilast under the NXP002 programme. The company also reported its Open Offer was oversubscribed by 408%, raising around £228,000 before expenses...
Cizzle Biotechnology Holdings

Cizzle Biotechnology to validate CIZ1B lung cancer test through NHS-linked partnership

Cizzle Biotechnology Chairman Derek Bickerstaff has confirmed the company has signed a Letter of Intent with a confidential NHS-affiliated diagnostics partner...
Ethtry plc

Ethtry confirms £1m strategic investment from MBS Global Investment

Ethtry has completed a £1 million investment from MBS Global Investment Co. L.L.C. for 400 million shares, giving MBS an 18.12 percent stake...
One Health Group

One Health Group schedules Interim Results update and Investor Webcast

One Health Group will release its interim results for the six months to 30 September 2025 on 1 December 2025...

Haleon appoints Vindi Banga as new Chair as Sir Dave Lewis steps down

Haleon has confirmed that Sir Dave Lewis will step down as Chair at the end of December 2025, with Vindi Banga appointed to take over from January 2026...
Ethtry plc

Ethtry receives additional £1.3m subscription funds ahead of second admission

Ethtry Plc has received a further £1.3 million from the outstanding balance of its £3.24 million subscription. The company will issue 522 million new ordinary shares, with Second Admission to the Aquis Growth Market expected on 11 November 2025...

Cizzle Biotechnology New NHS-Aligned Partnership Moves Lung Cancer Test Closer to UK Clinics (Video)

Cizzle Biotechnology has signed a letter of intent with an NHS-linked diagnostics partner to begin UK validation of its CIZ1B lung cancer test. Executive Chairman Dr Allan Syms outlines how this complements their existing US licence and supports national early detection targets...
Physicians Capital

Why medical office buildings are now core real estate

Medical office buildings are no longer niche, they’re now a core strategy for investors seeking income and stability...
Cizzle Biotechnology Holdings

Cizzle Biotechnology secures up to £250,000 in additional funding

Cizzle Biotechnology has raised up to £250,000 through additional unsecured convertible loan notes issued to existing investor Frazer Lang...
Cizzle Bio

Cizzle Biotechnology enters LOI with NHS partner to validate CIZ1B early cancer test

Cizzle Biotechnology has signed a Letter of Intent with a leading UK medical diagnostics provider working with the NHS to verify and validate its CIZ1B biomarker test for early lung cancer detection...
One Health Group

One Health Group Delivers Strong Interim Growth, Says Panmure Liberum

One Health Group posts strong interim results, with revenue and procedures ahead of expectations, highlighting growth amid NHS waiting list pressures...
Hutchmed

HUTCHMED unveils next-generation ATTC Platform and key R&D advances

HUTCHMED (China) Limited has introduced its next-generation Antibody-Targeted Therapy Conjugate (ATTC) platform and shared major pipeline updates at its 2025 R&D event...
Load More

News and Interview Alerts

Subscribe Free

Company Presentations

Q&As

Hardman & Co

Green News

View all Sustainable sectors, Plcs and news >>  

Search

Search

Latest Interviews

BrokerTalk

Funds

View all Funds, Market Insights and news >> 

FTSE 100 News

UK Broker Ratings

Search Results for: Except to morons like you who cherry pick data.

Aptamer Group

Aptamer Group AGM statement highlights contract wins and growing order book

Aptamer Group is holding its AGM today in York, where the Chairman will outline continued commercial progress, recent contract wins with major pharmaceutical companies, and an FY26 order book of £1.95 million...
intravenous (IV) line

AstraZeneca wins US approval for Imfinzi in early gastric and GEJ cancers

AstraZeneca has received US approval for Imfinzi combined with FLOT chemotherapy for adults with resectable early-stage and locally advanced gastric and gastroesophageal junction cancers...
AstraZeneca

AstraZeneca Plc to invest $2 billion in major Maryland manufacturing expansion

AstraZeneca has confirmed a $2 billion investment to expand its manufacturing presence in Maryland, including a larger biologics facility in Frederick and a new clinical manufacturing site in Gaithersburg...
GSK

GSK subsidiary TESARO starts legal action over Jemperli licence dispute

TESARO, part of GSK, has filed a case in the Delaware Chancery Court claiming AnaptysBio has breached its licence agreement for the cancer treatment Jemperli...
Halma plc

Halma Plc posts interim results and raises dividend by 7%

Halma plc has released its interim results for the six months to 30 September 2025, with full details available on its website and through the FCA’s National Storage Mechanism...
CVS Group plc

CVS Group reports steady sales growth and progress on strategy

CVS reported a 5.7 percent rise in sales and improved adjusted EBITDA for the four months to 31 October 2025, supported by stronger like for like growth and continued membership gains in its Healthy Pet Club scheme...
Ethtry plc

Ethtry appoints Patrick Chopard as new CEO

Ethtry PLC has named Patrick Chopard as its new Chief Executive Officer, bringing more than 15 years of financial markets experience from roles at Barclays, Deutsche Bank and Nomura...
Aptamer Group

Aptamer Group secures £192k contracts with global pharma, boosting FY26 order book to £1.95m

Aptamer Group announced two new contracts worth £192,000, including a fourth engagement with a top five global pharmaceutical company and a new deal targeting acute myeloid leukaemia...
Nuformix

Nuformix receives FDA clarification request and reports 408% oversubscription in Open Offer

Nuformix has received an FDA request for clarification on its Orphan Drug Designation application for tranilast under the NXP002 programme. The company also reported its Open Offer was oversubscribed by 408%, raising around £228,000 before expenses...
Cizzle Biotechnology Holdings

Cizzle Biotechnology to validate CIZ1B lung cancer test through NHS-linked partnership

Cizzle Biotechnology Chairman Derek Bickerstaff has confirmed the company has signed a Letter of Intent with a confidential NHS-affiliated diagnostics partner...
Ethtry plc

Ethtry confirms £1m strategic investment from MBS Global Investment

Ethtry has completed a £1 million investment from MBS Global Investment Co. L.L.C. for 400 million shares, giving MBS an 18.12 percent stake...
One Health Group

One Health Group schedules Interim Results update and Investor Webcast

One Health Group will release its interim results for the six months to 30 September 2025 on 1 December 2025...

Haleon appoints Vindi Banga as new Chair as Sir Dave Lewis steps down

Haleon has confirmed that Sir Dave Lewis will step down as Chair at the end of December 2025, with Vindi Banga appointed to take over from January 2026...
Ethtry plc

Ethtry receives additional £1.3m subscription funds ahead of second admission

Ethtry Plc has received a further £1.3 million from the outstanding balance of its £3.24 million subscription. The company will issue 522 million new ordinary shares, with Second Admission to the Aquis Growth Market expected on 11 November 2025...

Cizzle Biotechnology New NHS-Aligned Partnership Moves Lung Cancer Test Closer to UK Clinics (Video)

Cizzle Biotechnology has signed a letter of intent with an NHS-linked diagnostics partner to begin UK validation of its CIZ1B lung cancer test. Executive Chairman Dr Allan Syms outlines how this complements their existing US licence and supports national early detection targets...
Physicians Capital

Why medical office buildings are now core real estate

Medical office buildings are no longer niche, they’re now a core strategy for investors seeking income and stability...
Cizzle Biotechnology Holdings

Cizzle Biotechnology secures up to £250,000 in additional funding

Cizzle Biotechnology has raised up to £250,000 through additional unsecured convertible loan notes issued to existing investor Frazer Lang...
Cizzle Bio

Cizzle Biotechnology enters LOI with NHS partner to validate CIZ1B early cancer test

Cizzle Biotechnology has signed a Letter of Intent with a leading UK medical diagnostics provider working with the NHS to verify and validate its CIZ1B biomarker test for early lung cancer detection...
One Health Group

One Health Group Delivers Strong Interim Growth, Says Panmure Liberum

One Health Group posts strong interim results, with revenue and procedures ahead of expectations, highlighting growth amid NHS waiting list pressures...
Hutchmed

HUTCHMED unveils next-generation ATTC Platform and key R&D advances

HUTCHMED (China) Limited has introduced its next-generation Antibody-Targeted Therapy Conjugate (ATTC) platform and shared major pipeline updates at its 2025 R&D event...
Load More

News and Interview Alerts

Subscribe Free

Company Presentations

Q&As

Hardman & Co

Green News

View all Sustainable sectors, Plcs and news >>  

Search

Search

Latest interviews

Broker Talk

Funds

View all Funds, Market Insights and news >> 

FTSE 100 News

UK Broker Ratings

Health

Latest Interviews

FTSE 100 News

FTSE 250 News

News and Interview Alerts

Subscribe Free

Company Presentations

Q&As

Hardman & Co

BrokerTalk

FTSE 100

Funds

View all Funds, Market Insights and news >> 

Green News

View all Sustainable sectors, Plcs and news >>  

UK Broker Ratings

Follow us on Social Media:

Home X-twitter Linkedin Facebook Spotify Apple